LinM, LeePL, ChiuL, et al.Identification of novel fusion transcripts in multiple myeloma. J Clin Pathol, 2018; 71:708–712.
2.
FoulkB, SchafferM, GrossS, et al.Enumeration and characterization of circulating multiple myeloma cells in patients with plasma cell disorders. Br J Haematol, 2018; 180:71–81.
3.
LaganàA, PerumalD, MelnekoffD, et al.Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma. Leukemia, 2018; 32:120–130.
4.
LazzariE, MondalaPK, SantosND, et al.Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nat Commun, 2017; 8:1922.
5.
ManojlovicZ, ChristoffersonA, LiangWS, et al.Comprehensive molecular profiling of 718 Multiple Myelomas reveals significant differences in mutation frequencies between African and European descent cases. PLoS Genet, 2017; 13:e1007087.
6.
MillerA, AsmannY, CattaneoL, et al.High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma. Blood Cancer J, 2017; 7:e612.
